Multiple system atrophy (MSA) is a neurodegenerative disorder with limited treatment options. However, recent research has yielded potential developments into new therapeutic approaches. Current focus centers on modifying the underlying causes of MSA. One avenue under investigation involves drug-based interventions to regulate the dysregulation of